KHTRF fundamentals
Key facts
Market capitalization387.59 MUSD
Basic EPS (TTM)−0.22USD
Founded2013
CEOSamira Sakhia
Websitegud-knight.com
About
Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−36%
−24%
−12%
0%
12%
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
−25.00 M
0.00
25.00 M
50.00 M
75.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
KHTRF does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company